Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Price History  |  Ratios  |  Insiders

Spotlight Capital Holdings Inc (EM) SLCH

Spotlight Capital Holdings, Inc., through its subsidiaries, provides maintenance, repair, and overhaul products and services for aircraft in the general aviation sector in Florida. It offers various services that include federal aviation administration (FAA) certified repair station, major and minor airframe repairs, annual inspections, computerized aircraft weight and balance, aircraft modifications and STC kit installations, routine maintenance/insurance and accident repairs, composite airframe repairs, and pre-purchase inspections/log book analysis. The company also provides oxygen service/nitrogen service, service parts, janitrol/southwind heater service/AD compliance inspections, dye/fluorescent penetrant inspection service, aircraft exterior and interior detailing services, ACES dynamic propeller balancing service, avionics installations and repairs, minor paint repairs and detailing, instrument panel upgrades and component installs, engine scanners and monitor installation, a...


EXPM:SLCH - Post by User

Post by EllaMaeon Apr 18, 2022 2:16am
126 Views
Post# 34609133

FSD Pharma Inc: Lucid MS Video

FSD Pharma Inc: Lucid MS Video


FSD Pharma is delighted to announce pre-clinical findings indicating the efficacy of Lucid-MS, its flagship medication candidate, in treating Multiple Sclerosis. Lucid-MS's therapeutic potential is an industry first, and we'd like to provide visual evidence of functional recovery in pre-clinical individuals in this video!

<< Previous
Bullboard Posts
Next >>